CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
复制标题
CTHRC1 可能作为肝细胞癌的预后生物标志物
DOI:
10.2147/ott.s219429
复制
发表时间:
2019-01-01
影响因子:
4
通讯作者:
Sun, Dianxing
中科院分区:
文献类型:
--
作者:
Zhou, Huifang;Su, Libo;Sun, Dianxing
Background: Hepatocellular carcinoma is a common malignant cancer and the second most common cause of cancer-related deaths worldwide. Collagen triple helix repeat containing 1 (CTHRC1) has been increasingly reported to be involved in tumorigenesis and/or tumor progression. However, limited data are available regarding the role of CTHRC1 in hepatocellular carcinoma.Methods: Paraffin-embedded specimens from a total of 29 patients with HCC were collected in our study. The expression of CTHRC1 in hepatocellular carcinoma was evaluated using immunohistochemistry and bioinformatics analysis. Furthermore, Spearman analysis was performed to identify factors of correlation between CTHRC1 and clinicopathological features. Survival curves for hepatocellular carcinoma were produced using the Kaplan-Meier method and the log rank test.Results: In this study, we confirmed that CTHRC1 is highly expressed in tissues and hepatoma cell lines. The statistical analysis revealed that the levels of CTHRC1 were significantly correlated with cirrhosis (P=0.024), tumor size (P=0.006), vascular invasion (P